Go Deep
Lexeo Therapeutics, Inc.
Lexeo Therapeutics, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,269 | -2.7 | 0.96 | 0.03 | 260.94 |
| Oct 2026 | 22,338 | -2.6 | 0.92 | 0.03 | 249.71 |
| Oct 2026 | 22,256 | -2.8 | 0.96 | 0.03 | 262.09 |
| Oct 2026 | 22,332 | -2.6 | 0.92 | 0.03 | 250.05 |
| Oct 2026 | 22,256 | -2.7 | 0.96 | 0.03 | 261.69 |
| Oct 2026 | 22,092 | -3.0 | 1.05 | 0.03 | 286.35 |
| Oct 2026 | 22,105 | -2.9 | 1.05 | 0.03 | 283.75 |
| Oct 2026 | 22,174 | -2.8 | 1.01 | 0.03 | 272.79 |
Lexeo Therapeutics, Inc. Quarterly Results
Quarterly data isn't available for this company right now.
Lexeo Therapeutics, Inc. Revenue & Profit
Annual financial data isn't available for this company right now.
Lexeo Therapeutics, Inc. Balance Sheet
Balance sheet data isn't available for this company right now.
Owes vs Owns
Lexeo Therapeutics, Inc. owed $0.08 for every $1 it owned in Jun 2026, down from $2.16 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.08× | 0.08× | 0.20× | 0.19× | 2.16× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Lexeo Therapeutics, Inc. Cash Flow
Cash flow data isn't available for this company right now.